| Literature DB >> 34278133 |
Selvaraman Nagamani1, G Narahari Sastry1.
Abstract
The drug-resistant strains of Species">Mycobacterium tuberculosis (Entities:
Year: 2021 PMID: 34278133 PMCID: PMC8280707 DOI: 10.1021/acsomega.1c01865
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Performance of different machine learning models for the classification of M.tb permeable and impermeable compounds (RF, random forest; GBM, gradient boosting model; CART, classification and regression model; Glmnet, Lasso and elastic-net regularized generalized linear model; SVM, support vector machine; KNN, k-nearest neighbors; NB, naïve Bayes; and logistic, logistic regression).
Figure 2Optimization of RF models at different mtry and ntree values using top (A) 20 descriptors, (B) 40 descriptors, (C) 60 descriptors, (D) 80 descriptors, and (E) 100 descriptors as input features. Mtry is the number of variables randomly sampled as candidates at each split, and ntree is the number of trees to grow. The performance has been calculated by the percentage of OOB error.
Performance of RF Models at Different mtry Values Using Variable Number of Important Descriptorsa
| descriptors | mtry | sensitivity | specificity | precision | accuracy | MCC |
|---|---|---|---|---|---|---|
| Top 20 | 3 | 0.9814 | 0.8289 | 0.9420 | 0.9403 | 0.8455 |
| 4 | 0.9907 | 0.8289 | 0.9425 | 0.9692 | 0.8645 | |
| 5 | 0.9814 | 0.8205 | 0.9378 | 0.9412 | 0.8395 | |
| 6 | 0.9721 | 0.8289 | 0.9414 | 0.9130 | 0.8273 | |
| 7 | 0.9814 | 0.8289 | 0.9420 | 0.9403 | 0.8455 | |
| Top 40 | 2 | 0.9767 | 0.8158 | 0.9375 | 0.9254 | 0.8270 |
| 3 | 0.9814 | 0.8553 | 0.9505 | 0.9420 | 0.8641 | |
| 4 | 0.9907 | 0.8684 | 0.9552 | 0.9706 | 0.8918 | |
| 5 | 0.9814 | 0.8421 | 0.9462 | 0.9412 | 0.8548 | |
| 6 | 0.9860 | 0.8421 | 0.9464 | 0.9552 | 0.8641 | |
| Top 60 | 3 | 0.9953 | 0.8421 | 0.9469 | 0.9846 | 0.8832 |
| 5 | 0.9814 | 0.8289 | 0.9420 | 0.9403 | 0.8455 | |
| 7 | 0.9814 | 0.8158 | 0.9378 | 0.9394 | 0.8362 | |
| 9 | 0.9907 | 0.8205 | 0.9383 | 0.9697 | 0.8583 | |
| 11 | 0.9814 | 0.8289 | 0.9420 | 0.9403 | 0.8455 | |
| Top 80 | 36 | 0.9721 | 0.8421 | 0.9457 | 0.9143 | 0.8368 |
| 37 | 0.9721 | 0.8421 | 0.9457 | 0.9143 | 0.8368 | |
| 38 | 0.9953 | 0.8421 | 0.9469 | 0.9846 | 0.8832 | |
| 39 | 0.9587 | 0.8421 | 0.9457 | 0.8767 | 0.8115 | |
| 40 | 0.9814 | 0.8421 | 0.9462 | 0.9412 | 0.8548 | |
| Top 100 | 2 | 0.9814 | 0.8289 | 0.9420 | 0.9403 | 0.8455 |
| 4 | 0.9907 | 0.8421 | 0.9467 | 0.9697 | 0.8736 | |
| 6 | 0.9767 | 0.8421 | 0.9459 | 0.9275 | 0.8457 | |
| 8 | 0.9721 | 0.8421 | 0.9457 | 0.9143 | 0.8368 | |
| 10 | 0.9814 | 0.8421 | 0.9462 | 0.9412 | 0.8548 |
The top 40 descriptors at mtry 4 were selected as the best performing model. These descriptors were further optimized using the boosting method in XGBoost.
Figure 3ROC performance of the (A) gradient boosting model and (B) QSAR model on external validation data set (40 compounds).
Figure 4Schematic workflow for the development of M.tb permeability machine learning model.
Figure 5Significantly discriminating descriptors: (A) ETA_Epsilon_5, (B) nHBint5, (C) A log P, (D) MaxsOm, (E) Mpe, (F) GATS1e, (G) GATS3v, (H) MeanI, and (I) BUCTp.1l on the basis of Wilcoxon test (P < 0.05) among permeable and impermeable compounds.
The Top 10 Drug Molecules with Probable Tuberculosis Activity in PASS Prediction along with Docking Scores against 10 M.tb Targets
| docking
score (kcal/mol) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S. no. | drug name | phase | MOA | mtcA2 | folA | inhA | Cyp51 | folP1 | tmk | ligA | pknB | kasA | dprE1 | |
| 1 | Nomegestrol | approved | progestrone receptor agonist | 0.9793 | –7.5 | –10.9 | –11.9 | –11.7 | –9.1 | –8.4 | –9.4 | –10.2 | –8.6 | –10.6 |
| 2 | NGX267 | investigational | muscarinic acetylcholine receptor M1 | 0.956 | –5.0 | –6.6 | –7.0 | –7.2 | –6.0 | –5.7 | –6.1 | –6.4 | –6.7 | –7.6 |
| 3 | Gamolenic acid | approved and investigational | NA | 0.8674 | –5.7 | –7.6 | –7.8 | –8.0 | –6.1 | –7.5 | –6.4 | –6.9 | –7.6 | –7.8 |
| 4 | Tetrazepam | experimental | NA | 0.8559 | –6.3 | –9.2 | –10.7 | –9.6 | –8.9 | –7.2 | –9.0 | –9.5 | –8.3 | –9.1 |
| 5 | Nitrofural | approved and investigational | anti-infective agent | 0.7415 | –4.9 | –6.4 | –6.2 | –6.5 | –5.6 | –7.3 | –6.1 | –5.7 | –6.4 | –7.3 |
| 6 | Quinine | approved | hemozoin biocrystallization inhibitor | 0.6352 | –6.7 | –9.6 | –9.7 | –10.4 | –8.4 | –8.1 | –8.1 | –8.2 | –9.9 | –10.6 |
| 7 | Quinidine | approved and investigational | sodium channel blocker | 0.6352 | –6.8 | –9.6 | –9.7 | –10.4 | –8.4 | –8.6 | –8.1 | –8.2 | –8.8 | –9.7 |
| 8 | But-3-enyl-[5-(4-chloro-phenyl)-3,6-dihydro-[1,3,4]thiadiazin-2-ylidene]-amine | experimental | NA | 0.6175 | –5.6 | –7.7 | –7.5 | –8.2 | –6.6 | –7.6 | –7.0 | –6.6 | –6.8 | –8.0 |
| 9 | Lefamulin | approved and investigational | 50S ribosomal protein L22 | 0.5986 | –7.5 | –11.9 | –13.3 | –12.0 | –10.2 | –9.9 | –10.6 | –11.3 | –9.1 | –12.2 |
| 10 | Stavudine | approved and investigational | nucleoside reverse transcriptase inhibitor | 0.5958 | –6.1 | –7.2 | –7.3 | –7.7 | –6.3 | –8.6 | –6.6 | –6.3 | –7.3 | –8.0 |
Pa is the probability of active.